( 0 1 0 1 O
serum 1 6 1 6 B-clinical_variable
glutamate 7 16 7 16 I-clinical_variable
pyruvate 17 25 17 25 I-clinical_variable
transaminase 26 38 26 38 I-clinical_variable
[ 39 40 39 40 I-clinical_variable
SGPT 40 44 40 44 I-clinical_variable
] 44 45 44 45 I-clinical_variable
) 45 46 45 46 O
= 47 48 47 48 O
< 48 49 48 49 O
3.5 50 53 50 53 B-upper_bound
x 54 55 54 55 I-upper_bound
upper 56 61 56 61 I-upper_bound
limit 62 67 62 67 I-upper_bound
of 68 70 68 70 I-upper_bound
normal 71 77 71 77 I-upper_bound

Active 0 6 78 84 O
congestive 7 17 85 95 B-chronic_disease
heart 18 23 96 101 I-chronic_disease
failure 24 31 102 109 I-chronic_disease
( 32 33 110 111 O
New 33 36 111 114 B-clinical_variable
York 37 41 115 119 I-clinical_variable
Heart 42 47 120 125 I-clinical_variable
Association 48 59 126 137 I-clinical_variable
[ 60 61 138 139 I-clinical_variable
NYHA 61 65 139 143 I-clinical_variable
] 65 66 143 144 I-clinical_variable
class 67 72 145 150 I-clinical_variable
III 73 76 151 154 B-lower_bound
to 77 79 155 157 O
IV 80 82 158 160 B-upper_bound
) 82 83 160 161 O
, 83 84 161 162 O
symptomatic 85 96 163 174 O
ischemia 97 105 175 183 B-chronic_disease
, 105 106 183 184 O
or 107 109 185 187 O
conduction 110 120 188 198 O
abnormalities 121 134 199 212 O
uncontrolled 135 147 213 225 O
by 148 150 226 228 O
conventional 151 163 229 241 O
intervention 164 176 242 254 O

Any 0 3 255 258 O
serious 4 11 259 266 O
medical 12 19 267 274 O
condition 20 29 275 284 O
, 29 30 284 285 O
laboratory 31 41 286 296 O
abnormality 42 53 297 308 O
, 53 54 308 309 O
or 55 57 310 312 O
psychiatric 58 69 313 324 B-chronic_disease
illness 70 77 325 332 I-chronic_disease
that 78 82 333 337 O
would 83 88 338 343 O
prevent 89 96 344 351 O
the 97 100 352 355 O
subject 101 108 356 363 O
from 109 113 364 368 O
signing 114 121 369 376 O
the 122 125 377 380 O
informed 126 134 381 389 O
consent 135 142 390 397 O
form 143 147 398 402 O

Aspartate 0 9 403 412 B-clinical_variable
aminotransferase 10 26 413 429 I-clinical_variable
( 27 28 430 431 I-clinical_variable
AST 28 31 431 434 I-clinical_variable
) 31 32 434 435 I-clinical_variable
( 33 34 436 437 I-clinical_variable
serum 34 39 437 442 I-clinical_variable
glutamic 40 48 443 451 I-clinical_variable
oxaloacetic 49 60 452 463 I-clinical_variable
transaminase 61 73 464 476 I-clinical_variable
[ 74 75 477 478 I-clinical_variable
SGOT 75 79 478 482 I-clinical_variable
] 79 80 482 483 I-clinical_variable
) 80 81 483 484 I-clinical_variable
and 82 85 485 488 I-clinical_variable
alanine 86 93 489 496 I-clinical_variable
aminotransferase 94 110 497 513 I-clinical_variable
( 111 112 514 515 I-clinical_variable
ALT 112 115 515 518 I-clinical_variable
) 115 116 518 519 I-clinical_variable

Creatinine 0 10 520 530 B-clinical_variable
clearance 11 20 531 540 I-clinical_variable
( 21 22 541 542 I-clinical_variable
CrCl 22 26 542 546 I-clinical_variable
) 26 27 546 547 I-clinical_variable
> 28 29 548 549 O
= 29 30 549 550 O
45 31 33 551 553 B-lower_bound
mL 34 36 554 556 I-lower_bound
/ 36 37 556 557 I-lower_bound
minute 37 43 557 563 I-lower_bound
within 44 50 564 570 O
7 51 52 571 572 B-upper_bound
days 53 57 573 577 I-upper_bound
prior 58 63 578 583 I-upper_bound
to 64 66 584 586 O
enrollment 67 77 587 597 O
either 78 84 598 604 O
measured 85 93 605 613 O
or 94 96 614 616 O
calculated 97 107 617 627 O
using 108 113 628 633 O
a 114 115 634 635 O
standard 116 124 636 644 O
formula 125 132 645 652 O
( 133 134 653 654 O
eg 134 136 654 656 O
, 136 137 656 657 O
Cockcroft 138 147 658 667 B-clinical_variable
and 148 151 668 671 I-clinical_variable
Gault 152 157 672 677 I-clinical_variable
) 157 158 677 678 O

Disease 0 7 679 686 O
free 8 12 687 691 O
of 13 15 692 694 O
other 16 21 695 700 O
malignancies 22 34 701 713 B-cancer

Eastern 0 7 714 721 B-clinical_variable
Cooperative 8 19 722 733 I-clinical_variable
Oncology 20 28 734 742 I-clinical_variable
Group 29 34 743 748 I-clinical_variable
( 35 36 749 750 I-clinical_variable
ECOG 36 40 750 754 I-clinical_variable
) 40 41 754 755 I-clinical_variable
performance 42 53 756 767 I-clinical_variable
status 54 60 768 774 I-clinical_variable
0 61 62 775 776 B-lower_bound
- 62 63 776 777 O
2 63 64 777 778 B-upper_bound

Females 0 7 779 786 B-gender
of 8 10 787 789 O
childbearing 11 23 790 802 O
potential 24 33 803 812 O
( 34 35 813 814 O
FCBP 35 39 814 818 O
) 39 40 818 819 O
must 41 45 820 824 O
have 46 50 825 829 O
a 51 52 830 831 O
negative 53 61 832 840 B-pregnancy
serum 62 67 841 846 I-pregnancy
or 68 70 847 849 I-pregnancy
urine 71 76 850 855 I-pregnancy
pregnancy 77 86 856 865 I-pregnancy
test 87 91 866 870 O
with 92 96 871 875 O
a 97 98 876 877 O
sensitivity 99 110 878 889 O
of 111 113 890 892 O
at 114 116 893 895 O
least 117 122 896 901 O
50 123 125 902 904 B-lower_bound
mIU 126 129 905 908 I-lower_bound
/ 129 130 908 909 I-lower_bound
mL 130 132 909 911 I-lower_bound
within 133 139 912 918 O
24 140 142 919 921 B-upper_bound
hours 143 148 922 927 I-upper_bound
prior 149 154 928 933 I-upper_bound
to 155 157 934 936 O
the 158 161 937 940 O
initiation 162 172 941 951 O
of 173 175 952 954 O
the 176 179 955 958 O
study 180 185 959 964 O
and 186 189 965 968 O
they 190 194 969 973 O
must 195 199 974 978 O
agree 200 205 979 984 O
to 206 208 985 987 O
ongoing 209 216 988 995 O
pregnancy 217 226 996 1005 O
testing 227 234 1006 1013 O
and 235 238 1014 1017 O
to 239 241 1018 1020 O
practice 242 250 1021 1029 B-contraception_consent
contraception 251 264 1030 1043 I-contraception_consent

Known 0 5 1044 1049 O
history 6 13 1050 1057 O
of 14 16 1058 1060 O
allergy 17 24 1061 1068 O
to 25 27 1069 1071 O
Captisol 28 36 1072 1080 B-allergy_name

Known 0 5 1081 1086 O
sero 6 10 1087 1091 O
- 10 11 1091 1092 O
positive 11 19 1092 1100 O
for 20 23 1101 1104 O
active 24 30 1105 1111 O
viral 31 36 1112 1117 B-chronic_disease
infection 37 46 1118 1127 I-chronic_disease
with 47 51 1128 1132 O
human 52 57 1133 1138 B-chronic_disease
immunodeficiency 58 74 1139 1155 I-chronic_disease
virus 75 80 1156 1161 I-chronic_disease
( 81 82 1162 1163 I-chronic_disease
HIV 82 85 1163 1166 I-chronic_disease
) 85 86 1166 1167 I-chronic_disease
, 86 87 1167 1168 O
hepatitis 88 97 1169 1178 B-chronic_disease
B 98 99 1179 1180 I-chronic_disease
virus 100 105 1181 1186 I-chronic_disease
( 106 107 1187 1188 I-chronic_disease
HBV 107 110 1188 1191 I-chronic_disease
) 110 111 1191 1192 I-chronic_disease
or 112 114 1193 1195 O
hepatitis 115 124 1196 1205 B-chronic_disease
C 125 126 1206 1207 I-chronic_disease
virus 127 132 1208 1213 I-chronic_disease
( 133 134 1214 1215 I-chronic_disease
HCV 134 137 1215 1218 I-chronic_disease
) 137 138 1218 1219 I-chronic_disease

Left 0 4 1220 1224 B-clinical_variable
ventricular 5 16 1225 1236 I-clinical_variable
ejection 17 25 1237 1245 I-clinical_variable
fraction 26 34 1246 1254 I-clinical_variable
( 35 36 1255 1256 I-clinical_variable
LVEF 36 40 1256 1260 I-clinical_variable
) 40 41 1260 1261 I-clinical_variable
> 42 43 1262 1263 O
40 44 46 1264 1266 B-lower_bound
% 46 47 1266 1267 I-lower_bound

Male 0 4 1268 1272 B-gender
subjects 5 13 1273 1281 I-gender
must 14 18 1282 1286 O
agree 19 24 1287 1292 B-contraception_consent
to 25 27 1293 1295 I-contraception_consent
practice 28 36 1296 1304 I-contraception_consent
contraception 37 50 1305 1318 I-contraception_consent

Newly 0 5 1319 1324 O
diagnosed 6 15 1325 1334 O
acute 16 21 1335 1340 B-cancer
lymphoblastic 22 35 1341 1354 I-cancer
leukemia 36 44 1355 1363 I-cancer
/ 44 45 1363 1364 O
lymphoma 45 53 1364 1372 B-cancer

Pregnant 0 8 1373 1381 B-pregnancy
or 9 11 1382 1384 O
breast 12 18 1385 1391 O
feeding 19 26 1392 1399 O
females 27 34 1400 1407 B-gender

Subjects 0 8 1408 1416 O
with 9 13 1417 1421 O
pleural 14 21 1422 1429 B-chronic_disease
effusions 22 31 1430 1439 I-chronic_disease
requiring 32 41 1440 1449 O
thoracentesis 42 55 1450 1463 B-treatment
or 56 58 1464 1466 O
ascites 59 66 1467 1474 B-chronic_disease
requiring 67 76 1475 1484 O
paracentesis 77 89 1485 1497 B-treatment
within 90 96 1498 1504 O
14 97 99 1505 1507 B-upper_bound
days 100 104 1508 1512 I-upper_bound
prior 105 110 1513 1518 I-upper_bound
to 111 113 1519 1521 O
enrollment 114 124 1522 1532 O

Total 0 5 1533 1538 B-clinical_variable
bilirubin 6 15 1539 1548 I-clinical_variable
= 16 17 1549 1550 O
< 17 18 1550 1551 O
3 19 20 1552 1553 B-upper_bound
mg 21 23 1554 1556 I-upper_bound
/ 23 24 1556 1557 I-upper_bound
dL 24 26 1557 1559 I-upper_bound

Uncontrolled 0 12 1560 1572 B-chronic_disease
hypertension 13 25 1573 1585 I-chronic_disease
, 25 26 1585 1586 O
uncontrolled 27 39 1587 1599 O
pulmonary 40 49 1600 1609 B-chronic_disease
hypertension 50 62 1610 1622 I-chronic_disease
or 63 65 1623 1625 O
uncontrolled 66 78 1626 1638 B-chronic_disease
diabetes 79 87 1639 1647 I-chronic_disease
within 88 94 1648 1654 O
14 95 97 1655 1657 B-upper_bound
days 98 102 1658 1662 I-upper_bound
prior 103 108 1663 1668 I-upper_bound
to 109 111 1669 1671 O
enrollment 112 122 1672 1682 O

Unstable 0 8 1683 1691 B-chronic_disease
angina 9 15 1692 1698 I-chronic_disease
or 16 18 1699 1701 O
myocardial 19 29 1702 1712 B-chronic_disease
infarction 30 40 1713 1723 I-chronic_disease
within 41 47 1724 1730 O
6 48 49 1731 1732 B-upper_bound
months 50 56 1733 1739 I-upper_bound
prior 57 62 1740 1745 I-upper_bound
to 63 65 1746 1748 O
enrollment 66 76 1749 1759 O
, 76 77 1759 1760 O
NYHA 78 82 1761 1765 B-clinical_variable
class 83 88 1766 1771 B-lower_bound
III 89 92 1772 1775 I-lower_bound
or 93 95 1776 1778 O
IV 96 98 1779 1781 B-upper_bound
heart 99 104 1782 1787 B-chronic_disease
failure 105 112 1788 1795 I-chronic_disease
, 112 113 1795 1796 O
uncontrolled 114 126 1797 1809 B-chronic_disease
angina 127 133 1810 1816 I-chronic_disease
, 133 134 1816 1817 O
history 135 142 1818 1825 O
of 143 145 1826 1828 O
severe 146 152 1829 1835 O
coronary 153 161 1836 1844 B-chronic_disease
artery 162 168 1845 1851 I-chronic_disease
disease 169 176 1852 1859 I-chronic_disease
, 176 177 1859 1860 O
severe 178 184 1861 1867 O
uncontrolled 185 197 1868 1880 O
ventricular 198 209 1881 1892 B-chronic_disease
arrhythmias 210 221 1893 1904 I-chronic_disease
, 221 222 1904 1905 O
sick 223 227 1906 1910 B-chronic_disease
sinus 228 233 1911 1916 I-chronic_disease
syndrome 234 242 1917 1925 I-chronic_disease
, 242 243 1925 1926 O
or 244 246 1927 1929 O
electrocardiographic 247 267 1930 1950 O
evidence 268 276 1951 1959 O
of 277 279 1960 1962 O
acute 280 285 1963 1968 O
ischemia 286 294 1969 1977 B-chronic_disease
or 295 297 1978 1980 O
grade 298 303 1981 1986 B-chronic_disease
3 304 305 1987 1988 I-chronic_disease
conduction 306 316 1989 1999 I-chronic_disease
system 317 323 2000 2006 I-chronic_disease
abnormalities 324 337 2007 2020 I-chronic_disease
unless 338 344 2021 2027 O
subject 345 352 2028 2035 O
has 353 356 2036 2039 O
a 357 358 2040 2041 O
pacemaker 359 368 2042 2051 O

Use 0 3 2052 2055 O
of 4 6 2056 2058 O
any 7 10 2059 2062 O
other 11 16 2063 2068 O
experimental 17 29 2069 2081 B-treatment
drug 30 34 2082 2086 I-treatment
or 35 37 2087 2089 O
therapy 38 45 2090 2097 B-treatment
within 46 52 2098 2104 O
14 53 55 2105 2107 B-upper_bound
days 56 60 2108 2112 I-upper_bound
of 61 63 2113 2115 I-upper_bound
baseline 64 72 2116 2124 I-upper_bound

patients 0 8 2125 2133 O
who 9 12 2134 2137 O
are 13 16 2138 2141 O
sero 17 21 2142 2146 O
- 21 22 2146 2147 O
positive 22 30 2147 2155 O
because 31 38 2156 2163 O
of 39 41 2164 2166 O
hepatitis 42 51 2167 2176 B-chronic_disease
B 52 53 2177 2178 I-chronic_disease
virus 54 59 2179 2184 I-chronic_disease
vaccine 60 67 2185 2192 B-treatment
are 68 71 2193 2196 O
eligible 72 80 2197 2205 O

